Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Emergent Biosolutions Company Profile (NYSE:EBS)

Consensus Ratings for Emergent Biosolutions (NYSE:EBS) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $31.67 (5.66% upside)

Analysts' Ratings History for Emergent Biosolutions (NYSE:EBS)
Show:
DateFirmActionRatingPrice TargetDetailsShare
1/12/2015JPMorgan Chase & Co.Boost Price TargetOverweight$32.00 -> $34.00ViewTweet This Rating  Share This Rating on StockTwits
10/27/2014ZacksUpgradeNeutral -> Outperform$26.00ViewTweet This Rating  Share This Rating on StockTwits
8/12/2014ZacksReiterated RatingNeutral -> Neutral$25.00ViewTweet This Rating  Share This Rating on StockTwits
7/25/2014ZacksReiterated RatingNeutral -> Neutral$24.00ViewTweet This Rating  Share This Rating on StockTwits
5/15/2014Summer StreetInitiated CoverageBuy$35.00ViewTweet This Rating  Share This Rating on StockTwits
5/12/2014TheStreetDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
11/18/2013HSBCUpgradeNeutral -> OverweightViewTweet This Rating  Share This Rating on StockTwits
10/22/2013Deutsche BankBoost Price TargetHold€23.90 -> €24.00ViewTweet This Rating  Share This Rating on StockTwits
4/10/2013Janney Montgomery ScottInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
3/20/2013TheStreetDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
3/8/2013Cowen and CompanyReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
(Data available from 3/1/2013 forward)